Clinical Research Directory
Browse clinical research sites, groups, and studies.
RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
Sponsor: NYU Langone Health
Summary
The purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditation practice in otherwise healthy adults seeking to reduce cannabis use in the context of cannabis use disorder (CUD).
Official title: Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction Recovery Enhancement Stimulation) Initiative
Key Details
Gender
All
Age Range
22 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2025-11-12
Completion Date
2027-11-01
Last Updated
2025-11-13
Healthy Volunteers
No
Conditions
Interventions
Active Transcranial Direct Current Stimulation (tDCS)
tDCS is a noninvasive brain stimulation device that modulates brain activity by delivering low-intensity electrical current (2.0 mA) through scalp sponge electrodes. Device is programmed to ramp up to 2.0 mA (for 30 seconds), provide constant current throughout the session (19 minutes), and then ramp down (for 30 seconds) at the end.
Sham Transcranial Direct Current Stimulation (tDCS)
tDCS is a noninvasive brain stimulation device that modulates brain activity by delivering low-intensity electrical current (2.0 mA) through scalp sponge electrodes. Device is programmed to ramp up to 2.0 mA (for 30 seconds) followed by a ramp down (30 seconds), with no current delivery for 18 minutes, and then ramp up (for 30 seconds) and down (for 30 seconds) at the end.
Mindfulness meditation
Participants will follow an audio track for guided mindfulness during the stimulation.
Locations (1)
NYU Langone Health
New York, New York, United States